Early Data for ALS Drug Show Survival Benefit

(MedPage Today) -- Starting treatment earlier with an investigational, proprietary combination of sodium phenylbutyrate and taurursodiol--dubbed drug AMX0035--led to longer survival in patients with amyotrophic lateral sclerosis (ALS) in...